Guanfacine for the treatment of attention deficit hyperactivity disorder in children and adolescents

被引：8
|
作者：
Rizzo, Renata [1 ]
Martino, Davide [2 ,3 ]
机构：
[1] Univ Catania, Neuropsichiatria Infantile, Dipartimento Sci Med & Pediat, I-95123 Catania, Italy
[2] Kings Coll Hosp NHS Fdn Trust, Dept Neurol, London, England
[3] Queen Elizabeth Hosp, Lewisham & Greenwich NHS Trust, London, England
来源：
EXPERT REVIEW OF NEUROTHERAPEUTICS | 2015年 / 15卷 / 04期
关键词：
alpha(2)-adrenoreceptor agonist; attention deficit hyperactivity disorder; guanfacine extended-release; guanfacine immediate-release; treatment; EXTENDED-RELEASE; DEFICIT/HYPERACTIVITY DISORDER; DOUBLE-BLIND; OPEN-LABEL; LONG-TERM; PHASE-I; ADHD; PHARMACOKINETICS; PSYCHOSTIMULANTS; NEUROBIOLOGY;
D O I：
10.1586/14737175.2015.1028370
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Guanfacine is an (2A)-adrenoreceptor agonist currently indicated for the treatment of attention deficit hyperactivity disorder (ADHD). This article reviews the chemistry, pharmacodynamics and pharmacokinetics of guanfacine, as well as the clinical trial literature on guanfacine for the treatment of ADHD in children and adolescents, mainly focusing on the use of guanfacine extended-release (GXR). Six already published prospective randomized controlled trials (RCTs) and one unpublished RCT study were identified for GXR in the treatment of ADHD. All RCTs trials showed superiority over placebo on the primary outcome measure. Guanfacine, especially XR, seems to be an effective and safe treatment option for ADHD in children and adolescents.
引用
收藏
页码：347 / 354
页数：8
相关论文
共 50 条
  • [1] GUANFACINE EXTENDED RELEASE IN THE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER IN CHILDREN AND ADOLESCENTS
    Connor, D. F.
    Rubin, J.
    [J]. DRUGS OF TODAY, 2010, 46 (05) : 299 - 314
  • [2] Guanfacine extended release for the treatment of attention-deficit/hyperactivity disorder in children and adolescents
    Connor, Daniel F.
    Arnsten, Amy F. T.
    Pearson, Geraldine S.
    Greco, Gabriella F.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (11) : 1601 - 1610
  • [3] Guanfacine Extended Release: A Novel Treatment for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
    Faraone, Stephen V.
    McBurnett, Keith
    Sallee, Floyd R.
    Steeber, Jennifer
    Lopez, Frank A.
    [J]. CLINICAL THERAPEUTICS, 2013, 35 (11) : 1778 - 1793
  • [4] Guanfacine use in children with attention deficit hyperactivity disorder
    Cohn, LM
    Caliendo, GC
    [J]. ANNALS OF PHARMACOTHERAPY, 1997, 31 (7-8) : 918 - 919
  • [5] Guanfacine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents with Down Syndrome: A Retrospective Chart Review
    Powers, James H.
    Wu, Michael
    Palumbo, Michelle
    Keary, Christopher J.
    Mcdougle, Christopher J.
    Ravichandran, Caitlin
    Thom, Robyn P.
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2024, 34 (02) : 95 - 103
  • [6] GUANFACINE FOR TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER IN BOYS
    HORRIGAN, JP
    BARNHILL, LJ
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 1995, 5 (03) : 215 - 223
  • [7] Response to Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD)
    Turnbow, John
    Kollins, Scott
    Lopez, Frank
    Lyne, Andrew
    Youcha, Sharon
    Rubin, Jonathan
    [J]. BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 218S - 218S
  • [8] Attention deficit hyperactivity disorder in children and adolescents
    Flisher, A. J.
    Hawkridge, S.
    [J]. SOUTH AFRICAN JOURNAL OF PSYCHIATRY, 2013, 19 (03) : 136 - 140
  • [9] Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior stimulant treatment
    Huss, M.
    Hervas, A.
    Dirks, B.
    Bliss, C.
    Prochazka, J.
    Cutler, A.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S737 - S737
  • [10] Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment
    Huss, Michael
    Sikirica, Vanja
    Hervas, Amaia
    Newcorn, Jeffrey H.
    Harpin, Valerie
    Robertson, Brigitte
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 : 1085 - 1101
12345